| Primary |
| Drug Use For Unknown Indication |
24.1% |
| Perioperative Analgesia |
11.4% |
| Breast Cancer |
10.1% |
| Colorectal Cancer |
6.3% |
| Lymphoma |
6.3% |
| Vomiting |
6.3% |
| Prophylaxis |
5.1% |
| Prophylaxis Of Nausea And Vomiting |
5.1% |
| Antiemetic Supportive Care |
3.8% |
| Nausea |
3.8% |
| Chemotherapy |
2.5% |
| Glioblastoma |
2.5% |
| Lung Neoplasm Malignant |
2.5% |
| Premedication |
2.5% |
| Analgesic Therapy |
1.3% |
| Back Pain |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.3% |
| Epilepsy |
1.3% |
| Insomnia |
1.3% |
| Mantle Cell Lymphoma |
1.3% |
|
| Vertigo |
12.5% |
| Dyspnoea |
8.3% |
| Nausea |
8.3% |
| Colitis |
4.2% |
| Enterocolitis |
4.2% |
| Gastric Ulcer |
4.2% |
| Gastrointestinal Hypomotility |
4.2% |
| Hepatitis Cholestatic |
4.2% |
| Hypersensitivity |
4.2% |
| Ileus |
4.2% |
| Inappropriate Antidiuretic Hormone Secretion |
4.2% |
| Libido Increased |
4.2% |
| Megacolon |
4.2% |
| Neutropenia |
4.2% |
| Oculogyration |
4.2% |
| Pacemaker Complication |
4.2% |
| Presyncope |
4.2% |
| Pyrexia |
4.2% |
| Rash |
4.2% |
| Tachycardia |
4.2% |
|
| Secondary |
| Breast Cancer |
14.2% |
| Pancreatic Neoplasm |
12.0% |
| Acute Lymphocytic Leukaemia |
9.5% |
| Prophylaxis Of Nausea And Vomiting |
9.5% |
| Lymphoma |
8.0% |
| Prophylaxis |
6.2% |
| Leukaemia |
4.7% |
| Breast Cancer Metastatic |
4.4% |
| Premedication |
4.4% |
| Metastatic Malignant Melanoma |
3.6% |
| Nasal Cavity Cancer |
3.6% |
| Nausea |
2.5% |
| Pancreatic Carcinoma |
2.5% |
| Anaphylactic Reaction |
2.2% |
| Bone Sarcoma |
2.2% |
| Breast Cancer Stage Iii |
2.2% |
| Circulatory Collapse |
2.2% |
| Hypertension |
2.2% |
| Multiple Myeloma |
2.2% |
| Endocrine Pancreatic Disorder |
1.8% |
|
| Vomiting |
16.7% |
| Nausea |
14.6% |
| Thoracic Vertebral Fracture |
6.3% |
| Urinary Incontinence |
6.3% |
| Dyspnoea |
4.2% |
| Endometrial Hyperplasia |
4.2% |
| General Physical Health Deterioration |
4.2% |
| Inappropriate Antidiuretic Hormone Secretion |
4.2% |
| Lymphopenia |
4.2% |
| Neck Pain |
4.2% |
| Neutropenia |
4.2% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.2% |
| Puncture Site Infection |
4.2% |
| Transaminases Increased |
4.2% |
| Urinary Tract Infection |
4.2% |
| Acute Pulmonary Oedema |
2.1% |
| Alanine Aminotransferase Increased |
2.1% |
| Arthralgia |
2.1% |
| Atrial Fibrillation |
2.1% |
| Bile Duct Stenosis |
2.1% |
|
| Concomitant |
| Prophylaxis |
19.1% |
| Product Used For Unknown Indication |
11.8% |
| Premedication |
10.4% |
| Drug Use For Unknown Indication |
7.7% |
| Infection Prophylaxis |
5.6% |
| Colorectal Cancer |
4.5% |
| Prophylaxis Of Nausea And Vomiting |
4.3% |
| Hypertension |
3.7% |
| Bone Marrow Conditioning Regimen |
3.7% |
| Breast Cancer |
3.4% |
| Colon Cancer |
3.4% |
| Prophylaxis Against Graft Versus Host Disease |
3.1% |
| Nausea |
3.0% |
| Antiemetic Supportive Care |
2.9% |
| Acute Lymphocytic Leukaemia |
2.8% |
| Antifungal Prophylaxis |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Pain |
2.2% |
| Rectal Cancer |
1.9% |
| Multiple Myeloma |
1.8% |
|
| Vomiting |
11.3% |
| White Blood Cell Count Decreased |
11.3% |
| Pyrexia |
8.6% |
| Pneumonia |
7.5% |
| Interstitial Lung Disease |
6.4% |
| Dyspnoea |
5.5% |
| Nausea |
5.5% |
| Death |
5.3% |
| Febrile Neutropenia |
5.1% |
| Sepsis |
4.4% |
| Neutrophil Count Decreased |
4.2% |
| Peripheral Ischaemia |
3.5% |
| Weight Decreased |
3.1% |
| Neutropenia |
2.9% |
| Platelet Count Decreased |
2.9% |
| Stomatitis |
2.9% |
| Lymphocyte Count Decreased |
2.6% |
| Diarrhoea |
2.4% |
| Pleural Effusion |
2.4% |
| Decreased Appetite |
2.2% |
|
| Interacting |
| Lymphoma |
65.2% |
| Chronic Lymphocytic Leukaemia |
13.0% |
| Epilepsy |
13.0% |
| Nausea |
8.7% |
|
|
